Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

54.95
BATS BZX Real-Time Price
As of 11:54am ET
 +0.02 / +0.04%
Today’s Change
29.17
Today|||52-Week Range
77.80
-11.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.6B

Company Description

Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform. It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company and its partners. Its products are used to treat diseases such as severe and rare, cardiovascular, neurologic and metabolic diseases, and cancer. The company was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2741

Employees

Shareholders

Individual stakeholders6.88%
Mutual fund holders53.65%
Other institutional32.31%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer, Secretary & Director
Elizabeth L. HougenChief Financial Officer & SVP-Finance
C. Frank BennettSenior Vice President-Antisense Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development